PK

Pujitha Kiran Yeluchuri Kumari

Active Director Director DIN 07863085
DIN 07863085 First appointment Aug 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Pujitha Kiran Yeluchuri Kumari

Data last updated:

Pujitha Kiran Yeluchuri Kumari is a Director at Hascure Therapeutics Private Limited (since 2017). The company operates in Business Services.

DIN 07863085
Primary Designation Director
Industry Business Services
First Appointment 23 Aug 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hascure Therapeutics Private Limited U74999TG2017PTC119050
Director23 Aug 20172017Active

Board colleagues of Pujitha Kiran Yeluchuri Kumari

Directorship timeline

Open interactive timeline →
Hascure Therapeutics Private Limited
Premium access

Shareholding and investment profile for Pujitha Kiran Yeluchuri Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pujitha Kiran Yeluchuri Kumari

Pujitha Kiran Yeluchuri Kumari currently holds 1 directorship: Hascure Therapeutics Private Limited (Director, since 23 Aug 2017).

Pujitha Kiran Yeluchuri Kumari was first appointed on 23 Aug 2017 as Director at Hascure Therapeutics Private Limited.

The current boards of Pujitha Kiran Yeluchuri Kumari's companies include Hemalakshmi Gontla Surekha (Hascure Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available